Overview A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity Status: ACTIVE_NOT_RECRUITING Trial end date: 2026-05-01 Target enrollment: Participant gender: Summary The study is being conducted to evaluate the efficacy and safety of HRS-7535 in subjects with overweight or obesity.Phase: PHASE3 Details Lead Sponsor: Shandong Suncadia Medicine Co., Ltd.